Information Journal Paper
APA:
Copy. (2017). Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study. BMC NEUROLOGY, 17(1), 17-17. SID. https://sid.ir/paper/727799/en
Vancouver:
Copy. Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study. BMC NEUROLOGY[Internet]. 2017;17(1):17-17. Available from: https://sid.ir/paper/727799/en
IEEE:
Copy, “Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study,” BMC NEUROLOGY, vol. 17, no. 1, pp. 17–17, 2017, [Online]. Available: https://sid.ir/paper/727799/en